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Prospective neurocognitive evaluation of patients
undergoing carotid interventions
Wei Zhou, MD,a,b Elizabeth Hitchner, MA,a Kathleen Gillis, RNP,a Lixian Sun, MS,c
Rebecca Floyd, BS,d Barton Lane, MD,f and Allyson Rosen, PhD,d,e Palo Alto and Stanford, Calif
Objective: Distal cerebral embolization is a known complication of carotid interventions. We prospectively investigated
whether subclinical microembolization seen on postoperative magnetic resonance imaging (MRI) leads to cognitive
deficits in patients undergoing carotid revascularization procedures.
Methods: Patients undergoing carotid interventions and eligible for MRI scanning were recruited. Among 247 patients
who received preoperative and postoperative MRI evaluations, 51 also completed neuropsychologic testing before and at
1 month after their procedure. Cognitive evaluation included the Rey Auditory Verbal Learning Test (RAVLT) for
memory evaluation and the Mini-Mental State Examination (MMSE) for general cognitive impairment screening.
Results: The 51 patients (all men), comprising 16 with carotid artery stenting (CAS) and 35 with carotid endarterectomy
(CEA), were a mean age of 71 years (range, 54-89 years). Among them, 27 patients (53%) were symptomatic
preoperatively, including 11 who had prior stroke and 16 who had prior preoperative transient ischemic attack
symptoms. Most patients had significant medical comorbidities, including hypertension (96%), diabetes (31.3%),
coronary artery disease (47%), and chronic obstructive pulmonary disease (15.7%). Two patients (4%) had prior ipsilateral
CEA and eight had contralateral carotid occlusion (15.7%). Memory decline evident on RAVLT was identified in eight
CAS patients and 13 CEA patients. Eleven patients had evidence of procedure-related microemboli. Although there was
no significant difference in baseline cognitive function or memory change between the CEA and CAS cohorts, the CAS
cohort had a significantly higher incidence of microembolic lesions. Multivariate regression analysis showed that
procedure-related microembolization was associated with memory decline (P .016) as evident by change in RAVLT. A
history of neurologic symptoms was significantly associated with poor baseline cognitive function (MMSE; P .03) and
overall cognitive deterioration (change in MMSE; P  .026), as determined by Wilcoxon rank sum test and linear
regression analysis, respectively.
Conclusions: Although CEA and CAS are effective in stroke prevention, with minimal neurologic complication,
neurocognitive effects remain uncertain. Procedure-associated microembolization and pre-existing neurologic symptoms
are associated with poor baseline cognitive function and memory decline after the procedures. Further comprehensive
cognitive evaluation to determine the benefit of carotid interventions is warranted. (J Vasc Surg 2012;56:1571-8.)
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cManagement of stroke costs $45 billion annually and is
responsible for 1 million hospital admissions each year in
the United States.1 Prevention of stroke with safe treat-
ment of carotid disease is undoubtedly an important health
care goal in our society. Carotid endarterectomy (CEA)
and carotid artery stenting (CAS) are both safe and effective
options for stroke prevention in appropriately selected pa-
tients, with relatively low neurologic complication.2-7
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http://dx.doi.org/10.1016/j.jvs.2012.05.092owever, subclinical microembolization identified on
iffusion-weighted (DWI) magnetic resonance imaging
MRI) is common. We and others demonstrated that post-
perative MRI revealed procedure-related microemboli in
0% to 70% of CAS patients and in 10% to 20% of CEA
atients, despite absence of neurologic symptoms.8-15 A
ecent substudy of International Carotid Stenting Study
ICSS) trial confirmed three times more DWI lesions in the
AS than the CEA group.15 However, the clinical rele-
ance and long-term cognitive effects of microemboli asso-
iated with carotid interventions are largely unknown.
Although many studies have investigated the effects of
icroemboli on postoperative cognitive dysfunction after
ardiac surgery, only a limited number of studies have
ddressed the influence of microemboli on cognitive func-
ion among patients undergoing carotid revascularization
rocedures.16-18 The results among carotid patients are con-
roversial, and systemic evaluation of microemboli is generally
acking.19-21 We hypothesize that subclinical microemboliza-
ion moderates the degree of cognitive changes after carotid
nterventions and that certain risks are associated with
icroemboli. This study evaluated the cognitive effects of
icroemboli associated with carotid revascularization pro-
edures through a prospective, multidisciplinary team ap-
roach.
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published studies in consultation with a clinical neuropsy-
chologist. It included standard clinical measures and was
consistent with the recommendations by National Institute
of Neurological Disorders and Canadian Stroke Network,
as well as the consensus statement on neurobehavioral
outcomes after cardiovascular surgery.22,23 The battery was
designed to evaluate cognitive function across the major
cognitive domains, and the key outcome measure was Rey
Auditory Verbal Learning Test (RAVLT), a verbal world
list learning memory test that has been shown to be a
sensitive measure after carotid intervention.24 Other rele-
vant patient-related factors were also evaluated.
METHODS
This study was approved by Stanford University Inves-
tigational Review Board and the Palo Alto VAResearch and
Development Committee.
Patient selection. The study recruited patients with
high-grade carotid stenoses scheduled for CEA or CAS
interventions at the VA Palo Alto Health Care System.
CEA with patch angioplasty was performed under general
anesthesia using a standard protocol, with routine use of a
shunt device. CAS was performed in an endovascular suite
(GE Medical Systems, Milwaukee, Wisc), with routine use
of a distal embolic protection device, specifically Em-
boshield (Abbott, Abbott Park, Ill).
The indication for intervention complied with the stan-
dard clinical practice guideline, and revascularization pro-
cedures were offered to patients with 60% symptomatic
lesions or80% asymptomatic lesions. Diagnosis of carotid
stenosis was determined from carotid ultrasound velocity
criteria and North American Symptomatic Carotid Endar-
terectomy Trial criteria and confirmed with preoperative
magnetic resonance angiography (MRA) evaluations. CAS
was offered to patients who were high risk for CEA as
determined by criteria established at consensus conferences
and included various anatomic considerations such as pres-
ence of tracheostomy, history of ipsilateral neck irradiation,
prior radical neck dissection, or CEA.25
Nearly all patients routinely underwent a Persantine
Thallium (P-Thal) nuclear stress test, and cardiology eval-
uations were obtained for those with an abnormal stress test
result. Medical risk was stratified collaboratively among the
vascular surgeons, cardiologists, and internists. CEA and
CAS procedures were performed by experienced vascular
surgeons.
Exclusion criteria included inability to undergo MRI,
poorly controlled or untreated psychiatric diseases, history
of neurologic or systemic illness affecting the central ner-
vous system, non-English speakers, and the inability to
complete all study procedures.
Neuropsychologic battery. Study participants under-
went neuropsychologic testing at 1 to 2 weeks before and at
1 month after their procedure. At each test, a Mini-Mental
State Examination (MMSE) was performed to evaluate
general cognition, and a series of tests were performed to
assess the following different cognitive abilities: t. Memory: RAVLT
. Attention/Executive/Speed: Trail Making, Digit Span,
Color Word Interference
. Language: Category Fluency, Boston Naming Test
. Motor Skills: Grooved Pegboard
. Mood: Geriatric Depression Scale
t the first testing session, the Weschler Test of Adult
eading (WTAR) was also given to assess general intelli-
ence and to screen for gross abnormality before carotid
rocedures.
The two key neuropsychologic measures were the
MSE and RALVT. The MMSE is a brief mental status
xamination designed to provide a general clinical measure
f overall cognitive function by assessing performance on
he cognitive domains of orientation, language, calcula-
ion, memory, and visuospatial reproduction. The score on
heMMSE is the total number of items answered correctly,
ith a range of 0 to 30 points for the total score. Patients
ith MMSE 24 were considered severely cognitive im-
aired, scores of 24 to 28 indicated mild cognitive impair-
ent, and 28 was considered relatively normal. The
MSE has high test–retest reliability and has moderate
ensitivity. The MMSE was included as a brief measure of
lobal cognitive functioning and as a screen for obvious
ementia (cut score 24).
The RAVLT is a reliable and valid measure of verbal
emory and has psychometrically sound alternate forms
hat can reduce practice effects between follow-up appoint-
ents. RAVLT is designed to evaluate verbal word list
earning. The patient is presented with an original list of 15
ords five times and is asked to recall them immediately
fter each presentation. The patient is then presented with
nd asked to recall a second unrelated list (interference list)
f words. After the interference list, the patient is asked to
ecall the original list again. Finally, the patient is asked to
ecall the original list after a 20-minute delay without
urther presentation of those words.
RAVLT has been shown to be extremely sensitive (sen-
itivity, 90.2%; specificity, 84.2%) in discriminating healthy
lder adults from nondemented older adults with focal
emory deficit.26 In our study, the RAVLT score was
alculated as the sum of the words recalled in the first five
rials (RAVLT sum), and the change in score was deter-
ined by the difference between scores from preprocedural
nd postprocedural tests. Patients with negative change in
AVLT sum were compared with those with no change or
ositive change on RAVLT.
This neurocognitive battery was selected by a clinical
europsychologist (A.R.) and consistent with recommen-
ations by National Institute of Neurological Disorders
nd the Canadian Stroke Network as well as with the
onsensus statement on neurobehavioral outcomes after
ardiovascular surgery.22,23 It consisted of standard clinical
easures, partly because these tests have been widely vali-
ated in diverse populations of older adults and could be
eneralized for clinical use. The battery was also designed
o be briefly and reliably administered by trained personnel.
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Volume 56, Number 6 Zhou et al 1573MRI. Patients were scanned on a 1.5-Tmagnet (Signa
Excite HD 12.0; GE Medical Systems) equipped with a
head coil.27 The brain was scanned using multiple pulse
sequences in the axial, sagittal, and coronal planes accord-
ing to a standard clinical stroke protocol. MRI with DWI
sequences were performed for each patient preoperatively
and48 hours after the procedure to identify incidence of
microemboli. DWI was acquired with an echo-planar se-
quence, as we described previously.28 An apparent diffu-
sion coefficient map was automatically generated. The
scans were interpreted by a board-certified neuroradiolo-
gist who was blind to the clinical status of the patients.
A microembolus was identified as a new hyperintensity
on postoperative DWI with corresponded hypointensity on
the apparent diffusion coefficient map. Number and loca-
tion of microemboli were recorded. The intracranial vessels
were imaged using three-dimensional time-of-flight MRA
techniques, and the extracranial carotid and vertebral arter-
ies were imaged using precontrast two-dimensional time-
of-flight and postcontrast two-dimensional MRA tech-
niques.
Demographics and risk factors. For each participant,
age, sex, and risk factors were recorded, including smoking
history, hypertension (systolic blood pressure 140 mm
Hg, or diastolic blood pressure 90 mm Hg, or both),
hyperlipidemia (serum total cholesterol 200 mg/dL,
low-density lipoprotein  130 mg/dL, or triglyceride
200 mg/dL), severe coronary artery disease (CAD) with
reversibility on P-Thal, chronic obstructive pulmonary dis-
ease, atrial fibrillation, diabetes mellitus, obesity (bodymass
index 30 kg/m2), and peripheral vascular disease. Ana-
tomic risk factors were documented, including history of
ipsilateral CEA, ipsilateral neck surgery or radiation, and
contralateral carotid occlusion. Preoperative symptoms,
such as stroke or transient ischemic attack (TIA), and
postoperative neurologic symptoms were also analyzed.
For the CAS cohort, lesion calcification and aortic arch
classification were considered.
Statistical analysis. Patient data were collected on an
electronic spreadsheet and analyzed using SAS software
(SAS Institute, Cary, NC) in consultation with a statistician
(L.S.). Descriptive data were analyzed using a two-tailed
Student t-test and the Fisher exact test. Key independent
variables included type of procedure, incidence of micro-
emboli on postoperative DWI images, prior stroke, prior
TIA, aortic arch type, postprocedural neurologic problems,
and postprocedural administration of vasopressors.
Key dependent variables were scores on the RAVLT
andMMSE. The RAVLT score was calculated as the sum of
the words recalled in the first five trials (RAVLT sum), and
the change in score was determined by the difference
between scores from preprocedural and postprocedural
tests. A negative change in RAVLT sum indicated cognitive
decline, whereas no change or positive change indicated no
decline. The Fisher exact test and a two-sample t-test were
used to analyze the distribution of RAVLT change scores.
The Fisher exact test was also used to evaluate the distribu-
tion of MMSE baseline scores, and patients with scores
d
b28 were identified as impaired. The Wilcoxon rank sum
est and Kruskal-Wallis test were used to examine the
istribution of MMSE change. A linear regression was also
erformed to determine independent association between
he key independent variables and the key outcome mea-
ures (change in RAVLT and MMSE).
ESULTS
From 2004 to 2011, 247 patients who underwent
arotid revascularization procedures received preoperative
nd postoperativeMRI scans with DWI at the VA Palo Alto
ealth Care System. From this cohort, 69 patients were
rospectively enrolled in the study and received the neuro-
ognitive battery from February 2009 to May 2011, when
he neurocognitive battery was available and approved.
here was no difference in demographic characteristics or
eurologic complications between patients who received
he neurocognitive battery after February 2009 and those
ho did not in the earlier study period. Although there was
general trend of a lower incidence of microemboli in the
atients who received the neurocognitive battery (23%)
able I. A, Patient characteristics
ariablesa
CEA
(n  35)
CAS
(n  16) P
eneral risks
Age, years 72 (54-89) 68 (58-80) .2
History of smoking 28 (80) 12 (75) .723
Hypertension 34 (97) 15 (94) .533
Hyperlipidemia 30 (86) 12 (75) .436
Atrial fibrillation 2 (6) 2 (12.5) .581
Diabetes 10 (30) 6 (38) .534
Obesity 8 (23) 6 (38) .322
PVD 13 (37) 6 (38) .99
COPD 4 (11) 4 (25) .240
edication
Statin 26 (74.3) 15 (93) .14
ACE inhibitor 18 (51) 9 (53) .772
ardiovascular risks
Coronary artery disease 13 (37) 11 (69) .068
Reversibility on P-Thal 4 (11) 11 (69) .0001b
ymptoms
Prior stroke 7 (20) 4 (25) .723
Prior TIA 12 (34) 4 (25) .746
urgical risks
History of ipsilateral
CEA 0 (0) 2 (12.5) .094
Contralateral occlusion 1 (3) 7 (44) .0006b
aseline cognition
MMSE score 27.9  1.8 28.56  1.2 .17
RAVLT sum 32  10.2 35  8.9 .317
ost-op DWI lesions
Ipsilateral 3 (9) 8 (50) .0019b
Contralateral 0 (0) 3 (19) .0269b
CE, Angiotensin-converting enzyme; CEA, carotid endarterectomy;
OPD, chronic obstructive pulmonary disease; DWI, diffusion-weighted
maging; MMSE, Mini-Mental State Examination; P-Thal, Persantine
hallium; PVD, peripheral vascular disease; RAVLT, Rey Auditory Verbal
earning Test; TIA, transient ischemic attack.
Continuous variables are shown as median (range) or mean  standard
eviation and categoric variables as number (%).
Statistically significant.
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December 20121574 Zhou et alcompared with the earlier cohort who did not undergo the
neurocognitive testing (27.4%), the difference did not
reach significance. The analysis excluded 18 patients due to
inabilities to complete the neurocognitive battery, failed
screened tests, or withdrawal from the study, leaving 51
patients who completed the neuropsychologic testing.
Four patients who did not receive postoperative MRI
scan but completed neuropsychologic testing were ex-
cluded from the final analysis on cognitive outcomes.
The 18 patients who were completely excluded from the
study were a mean age 74.5 years, and most had a history
hypertension (94.4%), hyperlipidemia (94.4%), diabetes
(66.7%), and CAD (61%). Eight of the 18 patients
underwent CEA, and eight patients (44.4%) had symp-
tomatic carotid stenosis. Microemboli occurred in three
patients (16.7%), a similar incidence to those who were
included in the study.
All participants (mean age, 71 years) were men, of
whom 35 received CEA (mean age, 72 years) and 16
received CAS (mean age, 68 years). Patient demographics
are summarized in Table I, A. Most patients had a recent
history of smoking (78%) and hypertension (96%). Twenty-
seven patients (53%) were also symptomatic. There was no
significant difference in general risk factors between the
CEA and CAS cohorts, including age, smoking history,
hypertension, hyperlipidemia, atrial fibrillation, chronic ob-
structive pulmonary disease, diabetes mellitus, obesity, and
peripheral vascular disease. The CEA and CAS groups also
did not differ significantly in preoperative neurologic symp-
toms. However, CAS patients had a trend of higher CAD
Table I. B, The distribution of Mini-Mental State
Examination (MMSE) scores by predictors
Variable
Baseline cognition
P
MMSE 28
No. (%)
MMSE 28
No. (%)
Procedures (CAS  1)
0 17 (65.4) 18 (72)
1 9 (34.6) 7 (28) .7645
Post-DWI microemboli
0 17 (70.8) 19 (82.6)
1 7 (29.2) 4 (17.4) .4936
Prior stroke
0 22 (84.6) 18 (72)
1 4 (15.4) 7 (28) .3238
Prior TIA
0 14 (53.9) 21 (84)
1 12 (46.1) 4 (16) .0337
Arch type
1 12 (54.5) 14 (70)
2 6 (27.3) 4 (20)
3 4 (18.2) 2 (10) .6806
Post-op neurologic
complication
0 24 (92.3) 25 (100)
1 2 (7.7) 0 (0) .4902
CAS, Carotid artery stenting;DWI, diffusion-weighted imaging; TIA, tran-
sient ischemic attack.(69% vs 37%; P .068) and a significantly higher incidence af an abnormal initial cardiac stress test with reversibility on
-Thal (69% vs 11%; P  .001). CAS patients also had
igher surgical risks, such as prior ipsilateral CEA (12.5% vs
%; P .094) and preoperative contralateral carotid occlu-
ion (44% vs 3%; P  .001). Although there were no
ermanent neurologic complications, two CAS patients
ad transient neurologic attacks that were completely re-
olved at the time of the discharge. CAS patients also had a
ignificantly higher incidence of procedure-related con-
ralateral (19% vs 0%; P .0019) and ipsilateral (50% vs 9%;
 .0269) DWI abnormalities indicative of microemboli
Table I, A). These DWI lesions were heterogeneous in
istribution, consistent with our previous report.28
No significant difference was found in baseline cogni-
ive function between CEA and CAS patient cohorts. As
etermined by the MMSE, baseline cognitive function was
ow in 26 patients and relatively normal in 25. Each group
ad two patients who did not receive MRI. The Fisher
xact test showed there was no difference in the incidence
f microemboli between the patients who did and did not
ave low baseline cognitive function (Table I, B). Memory
ecline, as indicated by a decrease in performance on
AVLT, was found in 21 patients (41%), including 13CEA
nd eight CAS patients. No difference was detected in
emory change between CEA and CAS cohorts as assessed
y the two-sample Student t-test when each individual
core was considered or by the Fisher exact test when the
wo cohorts were compared (Table I, C). Changes in
AVLT and MMSE for each patient are displayed in Fig 1
able I. C, The distribution of Rey Auditory Verbal
earning Test (RAVTL) by predictors
redictor
RVVLT decline No RAVLT decline
P
(n  21) (n  30)
No. (%) No. (%)
AS
0 13 (61.9) 20 (71.43)
1 8 (38.1) 8 (28.57) .5474
ost-DWI
microemboli
0 12 (63.16) 22 (84.62)
1 7 (36.84) 4 (15.38) .1601
rior stroke
0 15 (71.43) 23 (82.14)
1 6 (28.57) 5 (17.86) .4937
rior TIA
0 14 (66.67) 20 (71.43)
1 7 (33.33) 8 (28.57) .7621
rch
1 6 (35.29) 18 (78.26)
2 8 (47.06) 2 (8.7)
3 3 (17.65) 3 (13.04) .0096
ost-op neurologic
complication
0 19 (90.48) 28 (100)
1 2 (9.52) 0 (0) .1786
AS, Carotid artery stenting;DWI, diffusion-weighted imaging; TIA, tran-
ient ischemic attack.nd Fig 2, respectively.
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Volume 56, Number 6 Zhou et al 1575To evaluate predictors of decline on RAVLT or
MMSE, the six most relevant factors that various studies
have shown affect cognitive function or incidence of
microemboli were included in our multiple linear regres-
sion models: age, procedure type, presence of procedure-
related DWI abnormality, preoperative TIA or stroke,
and postoperative neurologic complication. For CAS
patients, aortic arch anatomy was also evaluated. After
the procedure, microemboli were found in 11 patients,
including eight (50%) CAS and three (8.6%) CEA pa-
tients. Our regression analysis revealed that there was a
trend (P  .0525) toward memory decline for patients
with microemboli. Patients with procedure-related mi-
croemboli had a decrease in the mean RAVLT scores
from 32.7  12 preoperatively to 29.7  9.3 postoper-
atively, whereas those without microemboli had a
slightly increased RAVLTmean score from 33.3 8.8 to
34.2  9.4. There was also a trend (P  .0691) toward
memory decline in patients who experienced preopera-
tive TIA symptoms. Using a backward model selection,
where variables with a P  .15 were included in the
model, postprocedural DWI lesion was the only signifi-
cant predictor of decline on RAVLT (R2  .31; P 
.0162; Table II, A). Similarly, prior stroke and age were
significantly correlated with procedure-associated
MMSE change (P  .05) in our multiple linear regres-
sion model, and preoperative stroke symptom was the
only factor associated with MMSE change (P  .026)
Table II. A, Linear regression for change in Rey
Auditory Verbal Learning Test (RAVLT) using backward
model selection
Variable
Parameter
estimate SE Type II SS F Pr  F
Intercept –11.50436 9.16452 73.46335 1.58 0.2182
Post-DWI 6.72513 2.65482 299.15465 6.42 0.0162
Prior stroke 4.93897 2.73463 152.06910 3.26 0.0800
Prior TIA 4.73575 2.36036 187.66606 4.03 0.0531
Age 0.21896 0.12811 136.18863 2.92 0.0968
Post-DWI, Postoperative DWI lesion; Prior stroke, preoperative stroke symp-
tom; Prior TIA, preoperative transient ischemic attack symptom; SE, stan-
dard error; SS, sums of squares.
Table II. B, Linear regression for Mini-Mental State
Examination (MMSE) change using backwards model
selection
Variable
Parameter
estimate SE Type II SS F Pr F
Intercept 2.65855 1.84910 4.70997 2.07 0.1591
Prior stroke 1.39310 0.60007 12.28041 5.39 0.0260
Age 0.04864 0.02622 7.84090 3.44 0.0718
Prior stroke, Preoperative stroke symptom; SE, standard error; SS, sums of
squares.using a backward model selection (Table II, B). cISCUSSION
The cognitive effects of microemboli after carotid in-
ervention are largely unknown. Because microemboliza-
ion is increasingly recognized as an outcome measure of
arotid interventions, understanding the clinical relevance
f microemboli is essential. Our prospective evaluation
ighlighted that although microembolization is not signif-
cantly associated with overall cognitive change, it is an
ndependent predictor of memory decline after carotid
evascularization procedures. This study adds critical infor-
ation to our limited knowledge on carotid revascularization-
ssociated microembolization.
Several studies that evaluated cognitive outcomes after
arotid interventions showed controversial results.19-21
ehrner et al20 found that although overall cognitive func-
ioning did not dramatically change in most patients at 6
onths, significant improvement or deterioration in single
eurocognitive domains was demonstrated. The authors
ostulated that the magnitude of microemboli production
ight contribute to the discrepancy in cognitive domains,
ut microembolization was not examined. Lal et al29
howed that carotid revascularization resulted in an overall
mprovement in cognitive function and that CEA was
ssociated with a reduction in memory, whereas CAS pa-
ients showed reduced psychomotor speed. Similar to these
tudies, we also prospectively evaluated each cognitive do-
ain before and after carotid revascularization procedures.
urthermore, we systemically evaluated procedure-related
icroembolization and other significant risk factors.
Most of the studies that examined carotid procedure-
ssociated microembolization had limited neurocognitive
valuation. Gossetti et al19 identified microemboli in 44%
f CAS vs 4% of CEA patients and suggested that higher
ognitive decline in the CAS group was likely due to higher
mbolic load, but comprehensive cognitive testing was not
erformed. A study of 41 patients by Grunwald et al30
howed improvement in cognitive speed but not in mem-
ry function after an unprotected CAS. Unlike these stud-
es, we adapted a test battery that targeted patients with
ild cognitive dysfunction. The key outcome measure of
emory used in our study is particularly sensitive for early
lzheimer’s disease and mild cognitive impairment amnes-
ic subtype patients.26
One recent study byWasser et al31 did not show lasting
ognitive effects of microemboli when postprocedural test-
ng was performed 72 hours of the procedures. To avoid
he potential effect of anesthesia and to ensure that the
bserved cognitive changes would be enduring, we admin-
strated the postoperative neurocognitive battery at the
-month follow-up.We also used parallel forms of the word
ist memory test tominimize the practice effect. We showed
hat procedure-related microemboli was the only predictor
f memory decline at 1 month. Multiple studies on cardiac
urgery populations have confirmed that postoperative
ognitive dysfunction is a significant predictor of long-term
ognitive decline.32-35
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theNorth American Symptomatic Carotid Endarterectomy
Trial and the Asymptomatic Carotid Atherosclerosis Study
Fig 1. Scatter graph shows Rey Auditory Verbal Learnin
intervention. No significant difference was detected in me
coronary artery stenting (CAS) cohorts.
Fig 2. Scatter graph shows change in Mini-Mental
intervention. No significant difference was detected betw
stenting (CAS) cohorts.showed that surgical intervention was indicated for symp- comatic patients with 50% and asymptomatic patients
ith 60% carotid stenoses, it is generally accepted that
ost of the patients, particularly asymptomatic patients,
st (RAVLT) change scores for each patient after carotid
change between the carotid endarterectomy (CEA) and
Examination (MMSE) for each patient after carotid
the carotid endarterectomy (CEA) and coronary arteryg Te
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Volume 56, Number 6 Zhou et al 1577imens over the last decade.We and others have also adapted
a more conservative approach in treating patients with
carotid stenosis. Our standard practice, and the generally
accepted practice within the vascular community, is to raise
the interventional threshold. Therefore, our patients had
more severe diseases than the patients enrolled in North
American Symptomatic Carotid Endarterectomy Trial and
Asymptomatic Carotid Atherosclerosis Study trials as well
in as those in the recent Carotid Revascularization Endar-
terectomy Versus Stenting Trial trial.
Severe carotid disease could possibly have contributed
to the general poor neurocognitive function at baseline
among our patients. In addition, our CAS cohort had
significantly higher cardiovascular risks (reversibility on P-
Thal) and surgical risks (contralateral carotid occlusion).
The risk distribution was consistent with our standard
clinical practice guideline, because all patients underwent
risk stratification, and CAS was only offered to the high-risk
patients. All patients who underwent CAS received a distal
embolic protection device, namely Emboshield. Although
using the same embolic protection and stent devices limited
technical variability and learning curve-related inconsis-
tency, the study did not evaluate the effect of other embolic
protection devices, including flow reversal, on microembo-
lization.
Furthermore, although we found no difference in cog-
nitive function or memory changes between the CAS and
CEA cohorts, the CAS cohort had a significantly higher
microembolic rate, and the incidence of microemboli was
shown to be the only independent predictor of memory
decline using a linear regression model with backward
selection in our study. Differences in the effects of micro-
emboli between the two patient populations might possibly
be seen in a larger sample size.
We also showed trends of association between preop-
erative stroke symptoms and a decline in memory scores
and that preoperative stroke correlated with decline in
MMSE scores. These findings suggest that patients who
had a history of neurologic events were particularly at risk.
Our results also show that symptomatic patients had corre-
lated low baseline MMSE scores (P  .0337), suggesting
that these patients were at lower baseline cognitive func-
tional status. We postulate that existing brain injury may
predispose patients to memory and cognitive function de-
cline after these procedures.
In this study, we focused on changes in MMSE and
RAVLT.MMSEwas used as a general screen test for overall
cognitive function and RAVLT as the primary outcome
measure. Studies have demonstrated an association be-
tween memory decline and microemboli during cardiac
surgery,16-18 and overall score of verbal memory on the
RAVLT appeared to be a particularly sensitive measure of
neurocognitive changes after carotid interventions.24 Our
previous analysis showed that regions vulnerable to emboli
included those implicated in memory (posterior cingulate),
functions commonly affected in Alzheimer’s disease and
vascular dementia (unpublished data). We therefore fo-
cused on our sensitive primary outcome measure and sev-ral important risk factors in this initial evaluation. Other
isk factors and cognitive measures that aimed to compre-
ensively examine multiple cognitive domains not analyzed
n this study may also be affected. Large prospectively
ollected data and long-term comprehensive cognitive
valuation are warranted in the future.
ONCLUSIONS
Although the CEA and CAS cohorts did not differ
ignificantly in baseline cognitive function or memory
hange, the CAS cohort had a significantly higher incidence
f microembolic lesions. Our study showed an indepen-
ent association between microemboli and memory dete-
ioration after carotid interventions, signifying the clinical
mportance of microemboli. This study lays the founda-
ion for further investigation. It is our hope that with a
arger patient cohort, we will be better able to character-
ze why changes in cognition may be occurring for these
atients. Identifying a subgroup of patients susceptible
o procedure-related cognitive deterioration enables better
atient consultation and individualized patient care.
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